J. Craig Venter Institute|, Rockville, MD, 20850, USA.
Department of Biotechnology and Food Technology, Durban University of Technology, Durban, 4000, South Africa.
Microb Ecol. 2017 Nov;74(4):1001-1008. doi: 10.1007/s00248-017-0985-z. Epub 2017 May 11.
Ubiquitous in nature, antimicrobial resistance (AMR) has existed long before the golden age of antimicrobials. While antimicrobial agents are beneficial to combat infection, their widespread use contributes to the increase in and emergence of novel resistant microbes in virtually all environmental niches. The human microbiome is an important reservoir of AMR with initial exposure occurring in early life. Once seeded with AMR, commensal organisms may be key contributors to the dissemination of resistance due to the interconnectedness of microbial communities. When acquired by pathogens however, AMR becomes a serious public health threat worldwide. Our ability to combat the threat of emerging resistance relies on accurate AMR detection methods and the development of therapeutics that function despite the presence of antimicrobial resistance.
无处不在的性质,抗菌药物耐药性(AMR)存在已久,早在抗菌药物的黄金时代之前。虽然抗菌剂有利于对抗感染,但它们的广泛使用导致几乎所有环境小生境中新型耐药微生物的增加和出现。人类微生物组是 AMR 的一个重要储库,最初的暴露发生在生命早期。一旦被 AMR 定植,共生生物可能由于微生物群落的相互联系而成为耐药传播的主要贡献者。然而,当病原体获得 AMR 时,它就成为了全球范围内严重的公共卫生威胁。我们对抗新兴耐药性威胁的能力依赖于准确的 AMR 检测方法和开发在存在抗菌药物耐药性的情况下仍能发挥作用的治疗方法。